|
|
|
Home >
Anti-aging Research > Mistletoe
Iscador and Mistletoe
Where to purchase:
News & Research:
-
Mistletoe as medicine - Fox News Video, 12/21/12 - It's a six minute
video.
-
Could mistletoe give the kiss of death to cancer? - Science Daily,
11/30/12
-
Mistletoe in Supportive Care for Colorectal and Pancreatic Cancers -
Doctor's Guide, 7/12/07 - "Use of a fermented
mistletoe extract (MEx; Iscador®) in long-term supportive care in hospitals
and private practices demonstrated significant survival benefit and
improvements in quality of life for patients with surgically treated
primary, nonmetastatic colorectal carcinoma and for patients with all-stages
pancreatic carcinoma, when combined with adjuvant chemotherapy and/or
radiotherapy or passive aftercare in two multicentre, controlled,
retrospective, epidemiological, observational, cohort studies"
-
Mistletoe for
Cancer? Maybe Not - WebMD, 12/21/06
-
New Drugs Show
Promise in Hepatitis C Fight - WebMD, 5/18/04 -
"Mistletoe, Green Tomatoes, Novel Antiviral Drug May
Work When Standard Treatments Don't"
-
Mistletoe Extract May be Effective for Hepatitis C Patients Intolerant or
Unresponsive to Interferon and Ribavirin - Doctor's Guide, 5/18/04
- Studies Question
Benefit of Mistletoe for Cancer - Healthwell Exchange Daily News,
12/18/03
-
Study disputes value of mistletoe for cancer - CNN, 5/14/01 -
"Skin cancer metastasized to the brain in 19 percent
of the patients who took mistletoe, but in only 7 percent of the patients
who didn't take it"
- Under the
Mistletoe: Suzanne Somers' Breast Cancer Treatment, Tried-and-True Therapies
Offer Much Better Odds - WebMD, 4/4/01
-
Somers' self-treatment worries cancer experts - USA Today, 4/3/01
-
Somers' cancer treatment worries some experts - CNN, 3/30/01 -
""You do not look at one product like Iscador and
expect to reverse cancer," Burton Goldberg of Alternative Medicine magazine.
"It is not a magic bullet. Alternative physicians have to look at the
multiple causes of cancer, and they use multiple therapies in reversing the
system."
-
Herbal Aids for Cancer - Nutrition Science News, 3/00
- Anthroposophically
Extended Medicine: A First View - Ralph W. Moss, Ph.D, 1997 -
"I also met with Dr. Heiligtag, director of the
hospital, and with Dr. Michael Werner, director of the Hiscia institute
across the street from the Klinik. It is here that the world famous Iscador
is prepared from mistletoe (Viscum alba)"
Abstracts:
-
Curcumin and Viscum album
Extract Decrease Proliferation and Cell Viability of Soft-Tissue Sarcoma Cells:
An In Vitro Analysis of Eight Cell Lines Using Real-Time Monitoring and
Colorimetric Assays - Nutr Cancer. 2017 Jan 3:1-12 -
"Viscum album extract (VAE) ... soft-tissue sarcoma (STS) cells ...
Curcumin and VAE can inhibit the proliferation and viability of STS
cells" - See
Curcumin products at Amazon.com
and Viscum album extract at
Amazon.com.
-
Safety of Intravenous Application of Mistletoe (Viscum album L.)
Preparations in Oncology: An Observational Study - Evid Based
Complement Alternat Med. 2014;2014:236310 -
"Intravenous mistletoe therapy was found to be safe and prospective
studies for efficacy are recommended"
-
Case reports of sarcoma patients with optimized lectin-oriented
mistletoe extract therapy - J Altern Complement Med. 2011
Oct;17(10):973-9 - "Mistletoe (Viscum album
L) extracts (ME) are widespread as immunomodulatory therapeutic
agents in alternative tumor treatment. Assessing the
often-controversial clinical results is rather difficult since the
effects of ME on the immune system cannot be equally reproduced.
Mistletoe lectins (ML) are the only mistletoe ingredients also found
in vivo that are capable of having a positive effect on the immune
balance of patients with tumors. Other components have only been
tested in vitro, and the removal of mistletoe lectins ML from the
extract can put an end to the immunological efficacy of ME.
Preclinical investigations in the tumor models (using nude mice
xenotransplanted with human leiomyosarcoma and
interleukin-12-deficient C57BL6 mice) show that without
immunological reactions, ME induce less antitumor efficacy. ML,
functioning as ligands for pattern recognition receptors of the
natural immune system, are docked to ganglioside molecules (CD75) of
monocytes and granulocytes, thereby stimulating the natural
antitumor mechanisms. Objectives: The aim of this article is to
present and discuss several favorable clinical responses of patients
who had sarcoma and who were treated with immunologically effective
ME preparations. Course of therapy and results: In accordance with
the bell-shaped dose-response relationship of ML, the patients with
sarcoma were treated with ME preparations, standardized for the
active sugar-binding lectin contents. Thus, an optimal dose of
0.75-1.0 ng/kg ML was given twice a week subcutaneously. In this
report, the clinical progress of 6 patients with sarcoma showed
remissions of tumor symptoms. Conclusions: It seems that this
disease is beneficially influenced by optimized lectin-oriented ME
therapy since patients with sarcoma may react especially well to the
improved balance of natural immunological mechanisms" -
Note: Six out of how many???? It's an important part that was left
out. You can probably find a way to get Mistletoe via this website:
http://www.iscador.com/index.aspx
-
In vitro investigation into the potential of a mistletoe extract to
alleviate adverse effects of cyclophosphamide - Altern Ther
Health Med. 2010 May-Jun;16(3):40-8 -
"Mistletoe extract strongly stimulated healthy PBMC but not
malignant Jurkat cells. In addition, mistletoe extract seemed to
partially protect healthy PBMC-but not malignant Jurkat cells-from
the cytostatic effect of 4-hpc. The results motivate further
preclinical and clinical investigations of mistletoe extracts as an
adjuvant medication in cancer therapy to alleviate side effects of
conventional therapy"
-
Molecular
mechanisms of mistletoe plant extract-induced apoptosis in acute
lymphoblastic leukemia in vivo and in vitro - Cancer Lett. 2008
Feb 29 - "Aqueous mistletoe extracts (MT)
... Both MTs significantly improved survival (up to 55.4 days) at
all tested concentrations in contrast to controls (34.6 days)
without side effects"
Related Sites:
Where to purchase Iscador:
- http://www.weleda.com/
- URECH Konrad, Institute Hiscia, Society for Cancer Research, CH-4144
Arlesheim, Switzerland, Tel. +41 61 701 2323, Fax. +41 61 701 6274
- Weleda AG
Email from Michele Sanz
[michele@weleda.com] on 4/2/01:
Thank you for your interest in one of our products. ISCADOR®
is distributed under the brand name ISCAR® in the US by WELEDA, Inc., a division
of the Swiss company WELEDA-AG that has been specializing in complementary
medicine and natural skincare products for over 80 years.
ISCAR® is a “prescription only” homeopathic medicine, listed
with the FDA in accordance with their requirements for homeopathic medicines. It
is made from a homeopathic tincture of viscum album (mistletoe).
ISCADOR®/ISCAR® is a complementary rather than an alternative
medicine. It is frequently prescribed in Europe by Medical Doctors, including
oncologists, in addition to the conventional cancer therapies – radiation,
surgery and chemotherapy.
ISCAR® is indicated as a homeopathic medicine for adjunct
treatment of cancerous conditions as well as the conditions that frequently
accompany cancer - apathy, sadness, constipation and internal thermoregulation
problems. Many patients report an improvement in the quality of life and a
recent study shows that it increases the positive prognosis for cancer patients.
There are many different strengths of ISCAR® available and
your doctor will need to determine which is the correct one for you. Once you
have a prescription, you can order in one of the ways listed below:
. Mail your prescription for ISCAR® directly to us.
. Ask your doctor to order ISCAR® from us.
. Have your local pharmacy stock ISCAR® for you.
Sincerely yours,
Michele Sanz
Medical Services Manager
Weleda, Inc., 175 North Route 9W, Congers, NY 10920
(800) 241-1030 or (845) 268-8572 n Fax: (845) 268-8574 n
e-mail: rx@weleda.com n Internet: www.weleda.com
70225
|
|
